Santhera Pharmaceuticals AG is looking for a new partner for its Parkinson's disease drug fipamezole after Ipsen SA returned its rights to the drug, which covered territories outside of North America and Japan. Read More

LONDON – Pressing on with its mission of establishing regulatory pathways for more complex biosimilar drugs, the European Medicines Agency (EMA) published a draft guideline on a proposed route for approving interferon beta (IFN-beta) for treating multiple sclerosis. Read More

LONDON – Blocking a receptor molecule on natural killer (NK) cells in mice can protect the animals from serious viral infections that would normally kill them, researchers have shown. Read More

LONDON – BTG plc is celebrating its first regulatory approval after the FDA gave the nod to Voraxaze, an antidote to the chemotherapeutic methotrexate. Read More

Shares in 4SC AG surged more than 38 percent last week on news that its histone deacetylase (HDAC) inhibitor resminostat hit the primary endpoint of a Phase II trial in advanced hepatocellular carcinoma (HCC). Read More

• Applied Pharma Research SA (APR), of Balerna, Switzerland, Labtec GmbH, of Langenfeld, Germany, and Norgine BV, of Amsterdam, the Netherlands, signed an exclusive licensing agreement under which Norgine will market and distribute Setofilm, an ondansetron orally dispersible film strip, in Europe and selected countries in the Middle East, Africa and Australasia. Read More